Mesoblast Limited (ASX:MSB) Emerging Portfolio of Clinical Products Underpin Commercial Strategic Objectives
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced its half-yearly results.
Companies in the News
Biotech
Mesoblast Limited (ASX:MSB) First Group Of Heart Failure Patients Treated With "Off-The-Shelf" Adult Stem Cells Successfully Pass Key Safety Milestone
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) today announced successful achievement of the key safety milestone in the first low-dose cohort of patients treated with Revascor(tm), the proprietary allogeneic, or "off-the-shelf", universal adult stem cell product for congestive heart failure.
Starpharma Holdings Limited (ASX:SPL) Announces Its Financial Results For The 6 Months Ending 31 December 2008
Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) Net loss after tax was A$1.9 million, with operating cash outflows of A$2.5 million for the half year, 12% less than the same period in the prior year. Cash at 31 December was A$6.1 million. Total revenue and other income was A$5.1 million for the half year with revenue from continuing operations A$1.0 million for the six months, up 6% compared with the same period in the prior year.
Biota Holdings Limited (ASX:BTA) Interview With CEO Peter Cook
Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today reported NPAT of A$7.2 million for the first half ended December 2008, up 31 percent from the previous corresponding period. Excluding the A$20 million GlaxoSmithKline (GSK) litigation settlement, the underlying business booked a net loss of A$12.8 million for the half versus net profit of A$5.5 million previously.
Polartechnics Limited (ASX:PLT) Enters Global Sexually Transmitted Infection (STI) Market With A DNA Self-Sampling Device
Polartechnics (ASX:PLT)(PINK:PLTFF) proprietary self-sampling device, CerviScreen, has now been adapted to test for STI's including Chlamydia, Gonorrhoea and Trichomoniasis for both men and women. The new self-sampling target market for the STI device is sexually active men and women aged 15 to 50.
Biota Holdings Limited (ASX: BTA) Today Announces A Half Year Net Profit After Tax Of A$7.2 Million An Increase Of 31%
Biota Holdings Limited (ASX: BTA)(PINK:BTAHY) today announced a half year net profit after tax of A$7.2 million, (1H F08: A$5.5 million), a 31% improvement over first half F08. Profit before tax was A$10.1 million (1H F08: A$7.5 million) and includes A$12.7 million from the GSK litigation settlement in the period.
Mesoblast Limited (ASX:MSB) To Provide Cutting Edge Treatment Using Proprietary Adult Stem Cell Products
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) One of Singapore's leading private healthcare providers, Parkway Group Healthcare Pte Ltd, a subsidiary of Parkway Holdings Limited, and Australian regenerative medicine company, Mesoblast Limited, today announced a collaborative program to facilitate commercialisation of Mesoblast's proprietary "off-the-shelf" stem cell products within the extensive ParkwayHealth hospital network in Asia.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) LF-07 Intersects 54 Metres of net Coal
- Central Petroleum Limited (ASX:CTP) Live Online Investor Presentation
- State Gas Limited (ASX:GAS) Quarterly Activities Report
- Beetaloo Energy Australia Limited (ASX:BTL) Quarterly Activities Report - 30 June
- Basin Energy Ltd (ASX:BSN) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Share Buy-Back
Life Sciences
- Ellis Martin Report: Redefining Cancer Treatment - RenovoRx, Inc. (NASDAQ:RNXT) CEO Shaun Bagai on Targeted Pancreatic Therapy
- BPH Energy Limited (ASX:BPH) Quarterly Activities Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-Gen PromarkerD Test Performance Results Published
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
Social Media
